Skip to main content
SpringerLink
Log in

Thrombomodulin: cost effective in very low birth weight infants?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. year of costs not reported

Reference

  • Miyazawa T, et al. Cost-Effectiveness Analysis of the Treatment With Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation in Very Low Birth Weight Infants. 2014 Annual Meeting of the Pediatric Academic Societies : abstr. 2917.201, 3 May 2014. Available from: URL: http://www.abstracts2view.com/pas/view.php?nu=PAS14L1_2917.201

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thrombomodulin: cost effective in very low birth weight infants?. PharmacoEcon Outcomes News 704, 7 (2014). https://doi.org/10.1007/s40274-014-1290-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1290-4

Search

Navigation